About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Study Reveals Serious Gaps in Cancer Research

by VR Sreeraman on April 18, 2011 at 8:58 PM
Font : A-A+

 Study Reveals Serious Gaps in Cancer Research

A study has revealed serious gaps in cancer research, as several cancers with a high burden of disease are not receiving the clinical trial investment they require.

Dr Rachel Dear, a medical oncologist and PhD candidate at the University of Sydney, and coauthors used data from The Australian New Zealand Clinical Trials Registry to explore the association between cancer clinical trial activity, burden of disease and sponsorship sources.

Advertisement

"Four of the five cancers that result in the greatest burden of disease had relatively few clinical trials (lung, colorectal, prostate and pancreatic cancers)," Dr Dear said.

"We found that the number of trials for each cancer type did not always match the burden of disease caused by that cancer, thereby identifying gaps in cancer trials research," Dr Dear said.
Advertisement

Of 386 interventional cancer trials open to recruitment in Australia, breast cancer accounted for 62 trials. Yet only 24 trials were being conducted on lung cancer, despite it being responsible for the greatest burden of disease.

Dr Dear found that industry sponsorship is more likely for randomised controlled trials that investigate systemic therapies (drugs or biological agents) for patients with advanced cancers.

"Clinical trial registries are a largely untapped resource to describe the clinical research landscape and guide future trial activity," she said.

In an accompanying editorial, Professor Ian Olver of the Cancer Council Australia, said the study reflected the international situation, where investment in trials for specific cancer types does not correlate with the disease burden caused by those cancers.

Data from clinical trial registries have many applications. Clinicians and patients can search for trial options for specific conditions when standard treatments have been exhausted, or where no effective treatment exists, Professor Olver said.

"Data from clinical trial registries should be used to monitor the progress of such efforts to ensure Australia has a robust clinical trial capability."

Source: MJA
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Get Involved and Stand Up for Human Rights on Human Rights Day 2022
Coronary Artery Bypass Grafting
Macronutrients Calculator for Weight Loss
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 

Most Popular on Medindia

Turmeric Powder - Health Benefits, Uses & Side Effects Drug Side Effects Calculator Noscaphene (Noscapine) Hearing Loss Calculator Sanatogen Accident and Trauma Care Drug - Food Interactions Sinopril (2mg) (Lacidipine) A-Z Drug Brands in India Loram (2 mg) (Lorazepam)
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Study Reveals Serious Gaps in Cancer Research Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests